QOF · 2026/27

QOF — Quality & Outcomes Framework 2026/27

Last update

22 September 2026

Data source

Clinical system

Refresh

Weekly · live

Next refresh

Auto · weekly

Indicator type

Date window

PCN & Practice

View as at

KPIs on target

1/36

35 below · 4 monitoring

Performance

54.7%

34 payment KPIs

Highest performing

VI004

85.8% · target 50–60% · +25.8%

470 / 548

Lowest performing

CHOL003

15.2% · target 70–95% · -79.8%

1,210 / 7,947

Most improved

—

Needs 2+ uploads

On target (1)Near target (7)Below target (26)No data (6)Mon= Monitoring only — no payment threshold

Indicator⇅	Target⇅	Target activity⇅	Performance %⇅	Activity⇅	Population⇅	Shortfall⇅	Status
Respiratory
AST007Asthma with review in last 12 months▸	45–70%	9,731	45.5%	6,321	13,901	3,410	Below
AST012Asthma with objective tests recorded▸	45–80%	773	68.4%	661	966	112	Near
COPD010COPD with review including exacerbations, breathlessness▸	50–90%	3,204	40.2%	1,430	3,560	1,774	Below
Cardiovascular
AF006Patients with AF and CHA2DS2-VASc score▸	40–95%	769	70.7%	572	809	197	Below
AF008Patients with AF and a CHA2DS2-VASc score>=2 on DOAC /Vit K antagonist▸	70–95%	1,548	20.1%	328	1,629	1,220	Below
BP002Patients aged 45 or over and blood pressure recorded▸	50–90%	85,661	88.3%	84,024	95,178	1,637	Near
CHD005CHD taking anti-platelet or anti-coagulant▸	56–96%	5,928	88.6%	5,470	6,174	458	Near
CHOL003Patients with CHD / PAD / TIA / CKD on statin/lipid-lowering therapy▸	70–95%	7,550	15.2%	1,210	7,947	6,340	Below
CHOL004Patients with LDL cholesterol <=2.0 or non-HDL <=2.6▸	20–50%	4,258	37.7%	3,211	8,516	1,047	Below
HF007Heart failure with review of functional capacity, medication▸	50–90%	1,589	21.9%	387	1,765	1,202	Below
HF008Heart failure diagnosis from 1 April 2023 with ECHO or specialist assess▸	50–90%	701	82.9%	645	778	56	Near
HF009HF patients on ACE-I/ARB/ARNI, beta-blocker, MRA and SGLT2 inhibitor FYMon▸	Monitoring	—	8%	23	288	—	Monitoring
HYP008Hypertension aged 79 or under BP 140/90 mmHg or less▸	40–85%	20,207	54.1%	14,194	26,242	6,013	Below
HYP009Hypertension aged 80 or over BP 150/90 mmHg or less▸	40–85%	1,685	56.8%	1,196	2,106	489	Below
STIA007Non-haemorrhagic stroke or TIA taking anti-platelet or anti-coagulant▸	57–97%	1,727	87%	1,549	1,780	178	Near
Dementia
DEM004Dementia and review done▸	35–70%	757	26.2%	283	1,081	474	Below
Mental Health
MH002Mental health and care plan documented▸	40–90%	3,864	32.1%	1,378	4,293	2,486	Below
MH003Mental health problems and BP recorded in the preceding 12 months▸	50–90%	3,994	57.2%	2,540	4,437	1,454	Below
MH006Mental health problems and BMI recorded in the preceding 12 months▸	50–90%	3,978	53.5%	2,364	4,420	1,614	Below
MH007Mental health problems and alcohol recorded in last 12 months▸	50–90%	3,987	51.8%	2,294	4,429	1,693	Below
MH011Mental health problems and lipids recorded in last 12 months▸	50–90%	3,974	54%	2,386	4,415	1,588	Below
MH012Mental health problems and glucose/Hba1c recorded in last 12 months▸	NIS	—	—	1,534	—	—	No data
Diabetes
DM006Diabetes and proteinuria or micro-albuminuria taking ACE-I or ARB▸	57–97%	2,691	22.7%	631	2,774	2,060	Below
DM014Newly diagnosed with diabetes referred to structured education programme▸	40–90%	685	62.5%	476	761	209	Below
DM020Diabetes no moderate/severe frailty IFCC-HbA1c is 58 mmol/mol or less▸	35–75%	15,993	38.4%	8,182	21,323	7,811	Below
DM021Diabetes with frailty IFCC-HbA1c is 75 mmol/mol or less▸	NIS	—	—	1,478	—	—	No data
DM034Diabetes aged >=40 no CVD/frailty on statin or lipid-lowering therapy▸	50–90%	10,918	16.2%	1,965	12,131	8,953	Below
DM035Diabetes with CVD (not haemorrhagic) on statin or lipid-lowering therapy▸	50–90%	5,614	29.1%	1,817	6,237	3,797	Below
DM036Diabetes no moderate/severe frailty BP 140/90 mmHg or less▸	38–90%	20,317	62.7%	13,135	20,945	7,182	Below
DM037Diabetes with care processes performed in last 12 months FYMon▸	Monitoring	—	44.3%	10,693	24,121	—	Monitoring
Vaccination & Immunisation
VI001Three or more DTaP vaccine doses before 8 months▸	89–96%	3,820	64.4%	2,561	3,979	1,259	Below
VI002One or more MMR doses aged 12-18 months▸	86–96%	3,815	65.3%	2,594	3,973	1,221	Below
VI003Aged 1-5 years with DTaP/IPV booster and at least 2 doses of MMR▸	81–96%	3,408	70.2%	2,491	3,549	917	Below
VI004Aged 80 with shingles vaccine received between 70-79 years▸	50–60%	329	85.8%	470	548	Met	Met
Cervical Screening
CS005Aged 25-49 adequate smear last 3 years and 6 months▸	45–80%	65,879	54.6%	44,973	82,348	20,906	Below
CS006Aged 50-64 adequate smear last 5 years and 6 months▸	45–80%	14,099	77.4%	13,634	17,623	465	Near
Smoking
SMOK002Chronic disease and smoking status recorded▸	50–90%	53,867	85.1%	50,922	59,852	2,945	Near
SMOK004Current smokers with an offer of support given▸	40–90%	41,778	73.5%	34,135	46,420	7,643	Below
Obesity
OB004Patients age >=18 with obesity referred to weight management FYMon▸	Monitoring	—	—	2,074	—	—	Monitoring
OB005Patients NICE TA1026 cohort,shared decision,meds,behavioural referral FYMon▸	Monitoring	—	—	7	—	—	Monitoring

Data as of 22 September 2026 · Clinical system · Refreshed weekly